@drocon
Just ignore those down ramper and troll.
Great works new BOD.
All the best new BOD and shares holders
I like the forecast for FY2024
FY24 Outlook The Company is committed to delivering growth for shareholders in FY24 including:
• Net sales revenue $80m, representing a 35% increase on the previous year
• Gross profit margin of 40%
• Continued FDA progress
• Renewed focus on infant & adult goat nutrition
• Working capital improvements
• Improved transparency and governance
• Cash flow positive in FY25.
@drocon Just ignore those down ramper and troll. Great works new...
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $115.9M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $203.9K | 1.546M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1853083 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 346109 | 11 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| BUB (ASX) Chart |